Valerie Ceva

Chief Operating Officer at BioAegis Therapeutics, Inc.

Health Technology

Profile

Valerie Ceva has held positions as Chief Operating Officer & Director at BioAegis Therapeutics, Inc. and Secretary & Director at Azure Biotech, Inc. Her current job(s) include Chief Operating Officer & Director at BioAegis Therapeutics, Inc. and Secretary & Director at Azure Biotech, Inc.

Valerie Ceva active positions

Companies	Position	Start
BioAegis Therapeutics, Inc. BioAegis Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology BioAegis Therapeutics, Inc. manufactures medicinal chemicals. It develops a portfolio of biomarker-directed treatments for a range of indications. The company was founded by Susan L. Levinson and is headquartered in North Brunswick, NJ.	Chief Operating Officer	-
Azure Biotech, Inc. Azure Biotech, Inc. BiotechnologyHealth Technology Azure Biotech, Inc. is a private biotechnology company that is developing an alternative product to address the many drawbacks of current therapies for vulvovaginal atrophy (VVA). The company is based in New York, NY. The company has the exclusive worldwide rights to all topical formulations of lasofoxifene, a selective estrogen receptor modulator (SERM). Azure plans to rapidly build upon the extensive safety and efficacy data already available from clinical trials previously completed with an oral formulation in more than 15,000 women. The company was founded by David Thompson.	Director/Board Member	2013-07-31

All active positions of Valerie Ceva

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Valerie Ceva's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
BioAegis Therapeutics, Inc. BioAegis Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology BioAegis Therapeutics, Inc. manufactures medicinal chemicals. It develops a portfolio of biomarker-directed treatments for a range of indications. The company was founded by Susan L. Levinson and is headquartered in North Brunswick, NJ.	Health Technology
Azure Biotech, Inc. Azure Biotech, Inc. BiotechnologyHealth Technology Azure Biotech, Inc. is a private biotechnology company that is developing an alternative product to address the many drawbacks of current therapies for vulvovaginal atrophy (VVA). The company is based in New York, NY. The company has the exclusive worldwide rights to all topical formulations of lasofoxifene, a selective estrogen receptor modulator (SERM). Azure plans to rapidly build upon the extensive safety and efficacy data already available from clinical trials previously completed with an oral formulation in more than 15,000 women. The company was founded by David Thompson.	Health Technology